C.E Pharma
ActiveSummary
The computed 12-month bankruptcy probability of C.E Pharma is 3.1% (moderate). The 2025 annual accounts show negative equity (-€46,167) and a net result of -€17,197. Equity is shrinking by ~68.8% per year across the filed fiscal years. Its solvency ranks better than 17% of 22078 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Register details
Identification
Legal formPrivate limited company
Founded08-11-2022
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0793409817
Also
9925:BE0793409817
Registered
03-02-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 7 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Location & real-estate footprint
Registered office, Sint-Jans-Molenbeek · 1 establishment unit since 2022
Ground area
89 m²
Building footprint
92 m²
Volume, LiDAR
917 m³
Parcel 21523B0937/00G086, Brussels · tallest building 17.5 m, ±4 floors. Linked by address, not a title deed.
5
companies at this address
See who is registered here
1 establishment unit
Ransfortstraat 87, 1080 Sint-Jans-Molenbeek
since 2022unit no. 2.338.491.539
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21523B0937/00G086 | Brussels | 89 m² | 1 · 92 m² | 17.5 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.